- Home
- ALT vs LE Comparison
ALT vs LE Comparison
Compare ALT & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | LE |
|---|---|---|
| Founded | 1997 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.0M | 503.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ALT | LE |
|---|---|---|
| Price | $5.32 | $15.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $16.33 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 3.5M | 201.4K |
| Earning Date | 11-06-2025 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | $20,000.00 | ★ $1,314,437,000.00 |
| Revenue This Year | N/A | $2.21 |
| Revenue Next Year | N/A | $2.44 |
| P/E Ratio | ★ N/A | $40.85 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.90 | $7.65 |
| 52 Week High | $9.59 | $17.12 |
Technical Indicators
Market Signals| Indicator | ALT | LE |
|---|---|---|
| Relative Strength Index (RSI) | 61.41 | 48.86 |
| Support Level | $5.03 | $13.50 |
| Resistance Level | $5.83 | $17.12 |
| Average True Range (ATR) | 0.38 | 0.99 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 47.00 | 53.59 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically operates in USA, Europe, Asia, it derives a majority of its revenue from the United States.